THYROCARE.BO

Thyrocare Technologies Ltd · Healthcare · Diagnostics & Research

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$23.85B

PE Ratio

34.19028136798906

EV to Ebitda

—

Earnings Yield

241969357.33%

Revenue (TTM)

$45.9M

Net Income (TTM)

$8.8M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

-48.70%

Profit Margin

16.11%

Return on Equity

—

Debt to Equity Ratio

—

Dividend Yield

0.00%

All fundamentals

Core6 fields›

Market Cap$23.85B

Revenue TTM$45.9M

Shares Outstanding52.8M

Float15296605

Insider Ownership71.91%

Institutional Ownership23.94%

Growth Estimates5 fields›

Revenue Growth (Quarterly YoY)-48.70%

Rev Growth Est 1Y Forward0.1810

EPS Growth (Quarterly YoY)-99.20%

EPS Growth Est Quarterly0

LT EPS Growth Estimates20.30%

Operations14 fields›

Revenue TTM$45.9M

Gross Margin TTM68.42%

Gross Margin (Quarterly)68.09%

Operating Margin TTM27.35%

Operating Margin (Quarterly)13.83%

Profit Margin TTM16.11%

Profit Margin (Quarterly)11.48%

Net Income TTM$8.8M

EPS TTM11.317

EBIT Margin TTM36.17%

EBITDA TTM$16.6M

Capex % of Revenue TTM0.00%

Capital Expenditures$0.00M

FCF % of Revenue (Quarterly)19.90%

Efficiency1 fields›

ROA18.62%

Valuation7 fields›

P/E (TTM)34.19028136798906

P/E Forward0

EV/Revenues (TTM)6.2067

Price To Book4.864930836609958

Earnings Yield241969357.33%

Dividend Yield0.00%

Payout Ratio0.00%

Liquidity6 fields›

Current Ratio4.185058896466212

Goodwill & Intangibles$1013.00T

Total Assets$5706.90T

Total Liabilities$40.7M

Shareholders Equity$5137.40T

Interest Expense$22.5M

Yields3 fields›

Dividend Yield0.00%

Payout Ratio0.00%

Earnings Yield241969357.33%